Contera Pharma gets ₩3 billion funding from venture capital – Korea Biomedical Review

Contera Pharma gets ₩3 billion funding from venture capital – Korea Biomedical Review
Contera Pharma gets ₩3 billion funding from venture capital  Korea Biomedical ReviewContera Pharma, a Copenhagen-based subsidiary of Korean drugmaker Bukwang Pharm, said it has raised 3 billion won ($2.5 million) investment from Medici ... read more
Source: Google NewsPublished on 2019-07-10